Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Mar 31, 2023

Accession no.
0001415889-23-005669
Filed
Mar 31, 2023
Trade date
Mar 29-30, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.48M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (CHAIRPERSON & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 29, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
Mar 29, 2023Common StockSSaleDisposed−4,027$217.06F2−$874,100.624,103Direct
Mar 29, 2023Common StockSSaleDisposed−3,606$217.96F3−$785,963.76497Direct
Mar 29, 2023Common StockSSaleDisposed−367$218.56F4−$80,211.52130Direct
Mar 30, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
Mar 30, 2023Common StockSSaleDisposed−853$214.51F5−$182,977.037,277Direct
Mar 30, 2023Common StockSSaleDisposed−1,044$215.70F6−$225,190.86,233Direct
Mar 30, 2023Common StockSSaleDisposed−2,021$216.75F7−$438,051.754,212Direct
Mar 30, 2023Common StockSSaleDisposed−2,447$217.89F8−$533,176.831,765Direct
Mar 30, 2023Common StockSSaleDisposed−1,635$218.77F9−$357,688.95130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 29, 2023Common StockMOption exerciseDisposed−8,000$0.00$0184,000Direct
Mar 30, 2023Common StockMOption exerciseDisposed−8,000$0.00$0176,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $216.45 to $217.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $217.45 to $218.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $218.45 to $218.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $214.125 to $215.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $215.225 to $216.185. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $216.265 to $217.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $217.38 to $218.345. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $218.39 to $219.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)